Moreover, the results revealed that down-expression of GSN is an early event in bladder cancer development and is significantly correlated with high tumor stage (stages 2, 3 and 4) of BLCA patients (p < 0.01, Figure 7b). Here, GSN is linked to urinary bladder cancer.